Skip to content
Trial Eligibility
Menu

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

NCT07005154

This study is recruiting at 12 US sites in 11 states, according to its ClinicalTrials.gov record last updated .

Summary

Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen receptor pathway inhibitors (ARPIs) are another type of hormone therapy. They either slow down how much testosterone is made or block testosterone from reaching the prostate cancer cells. Abiraterone acetate (AA) is an ARPI that is used to treat advanced prostate cancer.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer
  • Metastatic Hormone Sensitive Prostate Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 years and older
Sex
Male
Healthy volunteers
Not accepted
Sponsor
Astellas Pharma Global Development, Inc.
Last updated on ClinicalTrials.gov
September 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • Clearview Cancer Institute · Huntsville, AL

California · 1

  • Sharp HealthCare - Sharp Memorial Hospital · San Diego, CA

Florida · 1

  • H. Lee Moffitt Cancer Center · Tampa, FL

Illinois · 2

  • Associated Urological Specialists · Chicago Ridge, IL
  • NorthShore University HealthSystem · Evanston, IL

Louisiana · 1

  • Ochsner Health - Ochsner Medical Center - New Orleans · New Orleans, LA

New Mexico · 1

  • New Mexico Oncology Hematology Consultants · Albuquerque, NM

Ohio · 1

  • Solaris Health - The Urology Group · Cincinnati, OH

South Carolina · 1

  • Carolina Urologic Research Center · Myrtle Beach, SC

Tennessee · 1

  • Tennessee Oncology Nashville · Nashville, TN

Virginia · 1

  • University of Virginia Cancer Center · Charlottesville, VA

Wisconsin · 1

  • UW Health Carbone Cancer Center · Madison, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.